UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ACAP2-TP63 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ACAP2-TP63 | FusionPDB ID: 1225 | FusionGDB2.0 ID: 1225 | Hgene | Tgene | Gene symbol | ACAP2 | TP63 | Gene ID | 23527 | 8626 |
Gene name | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | tumor protein p63 | |
Synonyms | CENTB2|CNT-B2 | AIS|B(p51A)|B(p51B)|EEC3|KET|LMS|NBP|OFC8|RHS|SHFM4|TP53CP|TP53L|TP73L|p40|p51|p53CP|p63|p73H|p73L | |
Cytomap | 3q29 | 3q28 | |
Type of gene | protein-coding | protein-coding | |
Description | arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2Arf GAP with coiled coil, ANK repeat and PH domains 2centaurin-beta-2 | tumor protein 63amplified in squamous cell carcinomachronic ulcerative stomatitis proteinkeratinocyte transcription factor KETtransformation-related protein 63tumor protein p53-competing protein | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | Q15057 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000326793, ENST00000472860, | ENST00000354600, ENST00000392461, ENST00000392463, ENST00000437221, ENST00000449992, ENST00000456148, ENST00000264731, ENST00000320472, ENST00000382063, ENST00000392460, ENST00000418709, ENST00000440651, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 16 X 14 X 11=2464 | 13 X 11 X 8=1144 |
# samples | 22 | 15 | |
** MAII score | log2(22/2464*10)=-3.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1144*10)=-2.93105264628251 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ACAP2 [Title/Abstract] AND TP63 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ACAP2(195065988)-TP63(189455529), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ACAP2-TP63 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACAP2-TP63 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACAP2-TP63 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ACAP2-TP63 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ACAP2 | GO:0030029 | actin filament-based process | 11062263 |
Tgene | TP63 | GO:0045747 | positive regulation of Notch signaling pathway | 11641404 |
Tgene | TP63 | GO:0045892 | negative regulation of transcription, DNA-templated | 12446784 |
Tgene | TP63 | GO:0045893 | positive regulation of transcription, DNA-templated | 12446784|16343436 |
Tgene | TP63 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 22521434 |
Tgene | TP63 | GO:2000271 | positive regulation of fibroblast apoptotic process | 9774969 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-GD-A2C5-11A | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000326793 | ACAP2 | chr3 | 195065988 | - | ENST00000264731 | TP63 | chr3 | 189455529 | + | 5333 | 575 | 213 | 2555 | 780 |
ENST00000326793 | ACAP2 | chr3 | 195065988 | - | ENST00000382063 | TP63 | chr3 | 189455529 | + | 5078 | 575 | 213 | 2300 | 695 |
ENST00000326793 | ACAP2 | chr3 | 195065988 | - | ENST00000418709 | TP63 | chr3 | 189455529 | + | 3295 | 575 | 213 | 1976 | 587 |
ENST00000326793 | ACAP2 | chr3 | 195065988 | - | ENST00000320472 | TP63 | chr3 | 189455529 | + | 2517 | 575 | 213 | 2045 | 610 |
ENST00000326793 | ACAP2 | chr3 | 195065988 | - | ENST00000392460 | TP63 | chr3 | 189455529 | + | 2181 | 575 | 213 | 2180 | 655 |
ENST00000326793 | ACAP2 | chr3 | 195065988 | - | ENST00000440651 | TP63 | chr3 | 189455529 | + | 2544 | 575 | 213 | 2543 | 776 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000326793 | ENST00000264731 | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + | 0.000292725 | 0.9997073 |
ENST00000326793 | ENST00000382063 | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + | 0.000355945 | 0.99964404 |
ENST00000326793 | ENST00000418709 | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + | 0.000404391 | 0.9995956 |
ENST00000326793 | ENST00000320472 | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + | 0.005500268 | 0.9944997 |
ENST00000326793 | ENST00000392460 | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + | 0.006919185 | 0.9930808 |
ENST00000326793 | ENST00000440651 | ACAP2 | chr3 | 195065988 | - | TP63 | chr3 | 189455529 | + | 0.006952806 | 0.9930472 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >1225_1225_1_ACAP2-TP63_ACAP2_chr3_195065988_ENST00000326793_TP63_chr3_189455529_ENST00000264731_length(amino acids)=780AA_BP=121 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKLVKLCIAMIDTGKAFCVANKQFMNGIRDLAQYSSNDAVVETSLTKFS DSLQEMINFHTILFDQTQRSIKAQLQNFVKDFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEP SEDGATNKIEISMDCIRMQDSDLSDPMWPQYTNLGLLNSMDQQIQNGSSSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTD YPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAP PSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGR DRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQ QQHQHLLQKQTSIQSPSSYGNSSPPLNKMNSMNKLPSVSQLINPQQRNALTPTTIPDGMGANIPMMGTHMPMAGDMNGLSPTQALPPPLS MPSTSHCTPPPPYPTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEHYSMDDLASLKIPEQFRHAIWKGILDHRQLHEFSSPSHLLRTP -------------------------------------------------------------- >1225_1225_2_ACAP2-TP63_ACAP2_chr3_195065988_ENST00000326793_TP63_chr3_189455529_ENST00000320472_length(amino acids)=610AA_BP=121 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKLVKLCIAMIDTGKAFCVANKQFMNGIRDLAQYSSNDAVVETSLTKFS DSLQEMINFHTILFDQTQRSIKAQLQNFVKDFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEP SEDGATNKIEISMDCIRMQDSDLSDPMWPQYTNLGLLNSMDQQIQNGSSSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTD YPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAP PSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGR DRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQ -------------------------------------------------------------- >1225_1225_3_ACAP2-TP63_ACAP2_chr3_195065988_ENST00000326793_TP63_chr3_189455529_ENST00000382063_length(amino acids)=695AA_BP=121 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKLVKLCIAMIDTGKAFCVANKQFMNGIRDLAQYSSNDAVVETSLTKFS DSLQEMINFHTILFDQTQRSIKAQLQNFVKDFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEP SEDGATNKIEISMDCIRMQDSDLSDPMWYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNE GQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARIC ACPGRDRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETY RQQQQQQHQHLLQKQTSIQSPSSYGNSSPPLNKMNSMNKLPSVSQLINPQQRNALTPTTIPDGMGANIPMMGTHMPMAGDMNGLSPTQAL PPPLSMPSTSHCTPPPPYPTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEHYSMDDLASLKIPEQFRHAIWKGILDHRQLHEFSSPSH -------------------------------------------------------------- >1225_1225_4_ACAP2-TP63_ACAP2_chr3_195065988_ENST00000326793_TP63_chr3_189455529_ENST00000392460_length(amino acids)=655AA_BP=121 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKLVKLCIAMIDTGKAFCVANKQFMNGIRDLAQYSSNDAVVETSLTKFS DSLQEMINFHTILFDQTQRSIKAQLQNFVKDFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEP SEDGATNKIEISMDCIRMQDSDLSDPMWPQYTNLGLLNSMDQQIQNGSSSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTD YPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAP PSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGR DRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQ QQHQHLLQKQTSIQSPSSYGNSSPPLNKMNSMNKLPSVSQLINPQQRNALTPTTIPDGMGANIPMMGTHMPMAGDMNGLSPTQALPPPLS -------------------------------------------------------------- >1225_1225_5_ACAP2-TP63_ACAP2_chr3_195065988_ENST00000326793_TP63_chr3_189455529_ENST00000418709_length(amino acids)=587AA_BP=121 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKLVKLCIAMIDTGKAFCVANKQFMNGIRDLAQYSSNDAVVETSLTKFS DSLQEMINFHTILFDQTQRSIKAQLQNFVKDFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEP SEDGATNKIEISMDCIRMQDSDLSDPMWPQYTNLGLLNSMDQQIQNGSSSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTD YPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAP PSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGR DRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQ -------------------------------------------------------------- >1225_1225_6_ACAP2-TP63_ACAP2_chr3_195065988_ENST00000326793_TP63_chr3_189455529_ENST00000440651_length(amino acids)=776AA_BP=121 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKLVKLCIAMIDTGKAFCVANKQFMNGIRDLAQYSSNDAVVETSLTKFS DSLQEMINFHTILFDQTQRSIKAQLQNFVKDFVETPAHFSWKESYYRSTMSQSTQTNEFLSPEVFQHIWDFLEQPICSVQPIDLNFVDEP SEDGATNKIEISMDCIRMQDSDLSDPMWPQYTNLGLLNSMDQQIQNGSSSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTD YPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAP PSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGR DRKADEDSIRKQQVSDSTKNGDAFRQNTHGIQMTSIKKRRSPDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQQHQ HLLQKQTSIQSPSSYGNSSPPLNKMNSMNKLPSVSQLINPQQRNALTPTTIPDGMGANIPMMGTHMPMAGDMNGLSPTQALPPPLSMPST SHCTPPPPYPTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEHYSMDDLASLKIPEQFRHAIWKGILDHRQLHEFSSPSHLLRTPSSAS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:195065988/chr3:189455529) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ACAP2 | . |
FUNCTION: GTPase-activating protein (GAP) for ADP ribosylation factor 6 (ARF6). {ECO:0000269|PubMed:11062263}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000264731 | 0 | 14 | 437_444 | 20.666666666666668 | 681.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000320472 | 0 | 12 | 437_444 | 20.666666666666668 | 511.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000354600 | 0 | 12 | 437_444 | 0 | 587.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000382063 | 0 | 13 | 437_444 | 20.666666666666668 | 596.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392460 | 0 | 13 | 437_444 | 20.666666666666668 | 556.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392461 | 0 | 10 | 437_444 | 0.0 | 417.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392463 | 0 | 11 | 437_444 | 0.0 | 462.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000418709 | 0 | 11 | 437_444 | 20.666666666666668 | 488.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000437221 | 0 | 9 | 437_444 | 0.0 | 394.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000440651 | 0 | 14 | 437_444 | 20.666666666666668 | 677.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000449992 | 0 | 11 | 437_444 | 0.0 | 502.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000456148 | 0 | 12 | 437_444 | 0.0 | 583.0 | Compositional bias | Note=Poly-Gln | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000264731 | 0 | 14 | 170_362 | 20.666666666666668 | 681.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000320472 | 0 | 12 | 170_362 | 20.666666666666668 | 511.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000354600 | 0 | 12 | 170_362 | 0 | 587.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000382063 | 0 | 13 | 170_362 | 20.666666666666668 | 596.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392460 | 0 | 13 | 170_362 | 20.666666666666668 | 556.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392461 | 0 | 10 | 170_362 | 0.0 | 417.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392463 | 0 | 11 | 170_362 | 0.0 | 462.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000418709 | 0 | 11 | 170_362 | 20.666666666666668 | 488.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000437221 | 0 | 9 | 170_362 | 0.0 | 394.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000440651 | 0 | 14 | 170_362 | 20.666666666666668 | 677.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000449992 | 0 | 11 | 170_362 | 0.0 | 502.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000456148 | 0 | 12 | 170_362 | 0.0 | 583.0 | DNA binding | . | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000264731 | 0 | 14 | 541_607 | 20.666666666666668 | 681.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000320472 | 0 | 12 | 541_607 | 20.666666666666668 | 511.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000354600 | 0 | 12 | 541_607 | 0 | 587.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000382063 | 0 | 13 | 541_607 | 20.666666666666668 | 596.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392460 | 0 | 13 | 541_607 | 20.666666666666668 | 556.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392461 | 0 | 10 | 541_607 | 0.0 | 417.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392463 | 0 | 11 | 541_607 | 0.0 | 462.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000418709 | 0 | 11 | 541_607 | 20.666666666666668 | 488.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000437221 | 0 | 9 | 541_607 | 0.0 | 394.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000440651 | 0 | 14 | 541_607 | 20.666666666666668 | 677.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000449992 | 0 | 11 | 541_607 | 0.0 | 502.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000456148 | 0 | 12 | 541_607 | 0.0 | 583.0 | Domain | Note=SAM | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000264731 | 0 | 14 | 394_443 | 20.666666666666668 | 681.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000264731 | 0 | 14 | 610_680 | 20.666666666666668 | 681.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000320472 | 0 | 12 | 394_443 | 20.666666666666668 | 511.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000320472 | 0 | 12 | 610_680 | 20.666666666666668 | 511.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000354600 | 0 | 12 | 1_107 | 0 | 587.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000354600 | 0 | 12 | 394_443 | 0 | 587.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000354600 | 0 | 12 | 610_680 | 0 | 587.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000382063 | 0 | 13 | 394_443 | 20.666666666666668 | 596.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000382063 | 0 | 13 | 610_680 | 20.666666666666668 | 596.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392460 | 0 | 13 | 394_443 | 20.666666666666668 | 556.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392460 | 0 | 13 | 610_680 | 20.666666666666668 | 556.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392461 | 0 | 10 | 1_107 | 0.0 | 417.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392461 | 0 | 10 | 394_443 | 0.0 | 417.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392461 | 0 | 10 | 610_680 | 0.0 | 417.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392463 | 0 | 11 | 1_107 | 0.0 | 462.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392463 | 0 | 11 | 394_443 | 0.0 | 462.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392463 | 0 | 11 | 610_680 | 0.0 | 462.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000418709 | 0 | 11 | 394_443 | 20.666666666666668 | 488.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000418709 | 0 | 11 | 610_680 | 20.666666666666668 | 488.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000437221 | 0 | 9 | 1_107 | 0.0 | 394.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000437221 | 0 | 9 | 394_443 | 0.0 | 394.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000437221 | 0 | 9 | 610_680 | 0.0 | 394.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000440651 | 0 | 14 | 394_443 | 20.666666666666668 | 677.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000440651 | 0 | 14 | 610_680 | 20.666666666666668 | 677.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000449992 | 0 | 11 | 1_107 | 0.0 | 502.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000449992 | 0 | 11 | 394_443 | 0.0 | 502.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000449992 | 0 | 11 | 610_680 | 0.0 | 502.0 | Region | Note=Transactivation inhibition | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000456148 | 0 | 12 | 1_107 | 0.0 | 583.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000456148 | 0 | 12 | 394_443 | 0.0 | 583.0 | Region | Note=Oligomerization | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000456148 | 0 | 12 | 610_680 | 0.0 | 583.0 | Region | Note=Transactivation inhibition |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 1_226 | 114.66666666666667 | 779.0 | Domain | Note=BAR |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 266_361 | 114.66666666666667 | 779.0 | Domain | PH |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 399_520 | 114.66666666666667 | 779.0 | Domain | Arf-GAP |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 640_669 | 114.66666666666667 | 779.0 | Repeat | Note=ANK 1 |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 673_702 | 114.66666666666667 | 779.0 | Repeat | Note=ANK 2 |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 706_735 | 114.66666666666667 | 779.0 | Repeat | Note=ANK 3 |
Hgene | ACAP2 | chr3:195065988 | chr3:189455529 | ENST00000326793 | - | 5 | 23 | 414_437 | 114.66666666666667 | 779.0 | Zinc finger | C4-type |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000264731 | 0 | 14 | 1_107 | 20.666666666666668 | 681.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000320472 | 0 | 12 | 1_107 | 20.666666666666668 | 511.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000382063 | 0 | 13 | 1_107 | 20.666666666666668 | 596.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000392460 | 0 | 13 | 1_107 | 20.666666666666668 | 556.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000418709 | 0 | 11 | 1_107 | 20.666666666666668 | 488.0 | Region | Note=Transcription activation | |
Tgene | TP63 | chr3:195065988 | chr3:189455529 | ENST00000440651 | 0 | 14 | 1_107 | 20.666666666666668 | 677.0 | Region | Note=Transcription activation |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ACAP2 | |
TP63 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ACAP2-TP63 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ACAP2-TP63 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |